T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Alnylam Pharmaceuticals
ALNY
$30.2B
| $1.11B | 0.1% |
6,535,368
+661,133
| +11% | +$123M |
|
|
SEE
202
DELISTED
Sealed Air
SEE
| $1.11B | 0.1% |
16,389,993
+274,800
| +2% | +$17.1M |
|
203
Welltower
WELL
$169B
| $1.1B | 0.1% |
12,815,380
-6,848,472
| -35% | -$571M |
|
204
SentinelOne
S
$7.76B
| $1.09B | 0.1% |
21,577,995
+8,460,448
| +64% | +$496M |
|
205
Alcon
ALC
$35.6B
| $1.09B | 0.1% |
12,394,124
+200,007
| +2% | +$16.5M |
|
206
Estee Lauder
EL
$32B
| $1.09B | 0.1% |
2,934,955
+57,854
| +2% | +$19.6M |
|
207
CVS Health
CVS
$122B
| $1.08B | 0.1% |
10,487,304
-137,315
| -1% | -$12.7M |
|
|
EXAS
208
DELISTED
Exact Sciences
EXAS
| $1.07B | 0.1% |
13,788,133
-4,716,911
| -25% | -$416M |
|
209
Sun Life Financial
SLF
$44.8B
| $1.07B | 0.1% |
19,163,972
-5,556
| -0% | -$307K |
|
210
Honeywell
HON
$73.9B
| $1.07B | 0.1% |
5,422,312
-1,055,373
| -16% | -$213M |
|
211
Martin Marietta Materials
MLM
$33.1B
| $1.06B | 0.1% |
2,405,585
+575,328
| +31% | +$233M |
|
212
Bright Horizons
BFAM
$3.82B
| $1.06B | 0.1% |
8,400,224
-898,309
| -10% | -$125M |
|
213
Republic Services
RSG
$66B
| $1.05B | 0.09% |
7,546,470
+1,560,354
| +26% | +$207M |
|
214
Snowflake
SNOW
$116B
| $1.05B | 0.09% |
3,104,594
+12,413
| +0.4% | +$4.33M |
|
215
Zimmer Biomet
ZBH
$19B
| $1.04B | 0.09% |
8,429,462
+424,878
| +5% | +$55.6M |
|
216
Clarivate
CLVT
$1.22B
| $1.04B | 0.09% |
44,092,063
-4,477,503
| -9% | -$104M |
|
217
Costco
COST
$423B
| $1.03B | 0.09% |
1,812,145
-15,766
| -0.9% | -$8.08M |
|
|
SGEN
218
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.03B | 0.09% |
6,635,246
-354,618
| -5% | -$59.4M |
|
219
O'Reilly Automotive
ORLY
$75.7B
| $1.02B | 0.09% |
21,708,780
-5,726,325
| -21% | -$248M |
|
220
SiteOne Landscape Supply
SITE
$4.26B
| $1.02B | 0.09% |
4,195,186
+186,275
| +5% | +$43.1M |
|
221
CF Industries
CF
$17.7B
| $1.02B | 0.09% |
14,349,469
-5,338,166
| -27% | -$334M |
|
222
EOG Resources
EOG
$73.7B
| $1B | 0.09% |
11,262,233
-2,696,567
| -19% | -$242M |
|
223
TotalEnergies
TTE
$190B
| $990M | 0.09% |
20,016,824
-254,462
| -1% | -$12.7M |
|
224
Live Nation Entertainment
LYV
$43.7B
| $983M | 0.09% |
8,209,707
-595,843
| -7% | -$64.2M |
|
225
Workday
WDAY
$44.2B
| $982M | 0.09% |
3,592,970
-687,876
| -16% | -$191M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.